(MENAFN- EIN Presswire)
Veterinary Oncology Market
Global veterinary oncology market is estimated to be valued at USD 724.9 Mn in 2024 and is expected to reach USD 1,563.7 Mn by 2031
BURLINGAME, CA, UNITED STATES, October 21, 2024 /EINPresswire / -- The latest market intelligence report published by CMI with the title "Global Veterinary Oncology Market 2024, Growth Opportunities, and Forecast" provides actionable insights on
Pharmaceutical industry. The report provides demand analysis,
industry insights, competitive intelligence, and customer database.
The Research report on Veterinary Oncology Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five Forces Analysis, PESTLE Analysis, Value Chain Analysis, 4 Ps' Analysis, Market Attractiveness Analysis, BPS Analysis, Ecosystem Analysis.
Do you think, if this report could be of your interest? If yes, request Sample Copy of this Report: : -
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.
Key Trends of Veterinary Oncology Market
- New Advancements in Diagnostics: Next-gen screening techniques like liquid biopsy and AI-powered image analysis are enabling earlier and more precise cancer detection in pets.
- Personalized Treatment Plans: Veterinarians can now develop tailored treatment regimens leveraging genetic testing, immunotherapy, and targeted therapies. This holistic approach improves outcomes.
- Growth in Specialized Care Centers: Dedicated oncology practices with specialized surgeons and medical oncologists are reducing treatment costs and improving access in major cities.
- Rising Pet Insurance Adoption: More pet owners are opting for comprehensive insurance plans that cover cancer care. This is stimulating demand for advanced therapies.
- Multi-disciplinary Research Partnerships: Collaborations between veterinary schools, OEMs, and biotechs are accelerating clinical trials and approving new therapies originally developed for human cancers.
Want to access more insights? The journey starts from requesting Sample: : -
*Note: Sample of the report provides details on the scope and coverage, table of contents, research methodology, and Sample Framework of the report. Actual report of 150+ is available for purchase to all the interested stakeholders.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2031, Y-o-Y growth rate, and CAGR):
By Animal Type: Companion Animal (Equine, Canine, and Feline) and Livestock Animal
By Therapy Type: Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy
By Mode of Administration: Oral and Intravenous
By Application: Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Others
By Distribution Channel: Hospital Pharmacies, Government Agencies, and Retail Pharmacies
. By Regions and Countries
o North America
o Europe
o Asia-Pacific
o South America
o Middle East & Africa
Following are the players analyzed in the report:
Zoetis Inc.
Elanco
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
VetDC
Morphogenesis Inc.
Karyopharm Therapeutics Inc.
Regeneus Ltd.
AdvaVet Inc.
Rhizen Pharmaceutical SA.
PetCure Oncology
Varian Medical Systems
Accuray Incorporated
Merck Animal Health
Regeneus Ltd.
VolitionRx Limited
Get access to the latest Edition of this Market Study (comprising 150+ pages) and Get Up to 35% Discount: :
Deep-dive Analysis:
The Report provides deep-dive qualitative and quantitative analysis on Veterinary Oncology Market for all the regions and countries covered below:
➢ North America (the United States, Canada, and Mexico)
➢ Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe)
➢ Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
➢ South America (Brazil, Argentina, and Rest of South America)
➢ Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa)
➢ Each Country is covered in detail, and report provides qualitative and quantitative analysis on Veterinary Oncology Market on each country.
The research provides answers to the following key questions:
1.What is the estimated growth rate of the market for the forecast period 2024-2031? What will be the market size during the estimated period?
2.What are the key driving forces responsible for shaping the fate of the Veterinary Oncology market during the forecast period?
3.Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Veterinary Oncology market?
4.What are the prominent market trends influencing the development of the Veterinary Oncology market across different regions?
5.What are the major threats and challenges likely to act as a barrier in the growth of the Veterinary Oncology market?
6.What are the major opportunities the market leaders can rely on to gain success and profitability?
Key insights provided by the report that could help you take critical strategic decisions?
. Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.
. Reports provide opportunities and threats faced by suppliers in the Veterinary Oncology and tubes industry around the world.
. The report shows regions and sectors with the fastest growth potential.
. A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.
. The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.
. This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
. This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.
Author of this marketing PR:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN21102024003118003196ID1108801039